Anzeige
Mehr »
Login
Mittwoch, 22.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWP | ISIN: US34960Q3074 | Ticker-Symbol: CNB1
NASDAQ
21.05.24
21:43 Uhr
1,930 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
FORTRESS BIOTECH INC Chart 1 Jahr
5-Tage-Chart
FORTRESS BIOTECH INC 5-Tage-Chart

Aktuelle News zur FORTRESS BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrFortress Biotech files for $50M mixed shelf5
DoFortress Biotech, Inc.: Fortress Biotech to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase1
15.05.Fortress Biotech Inc reports results for the quarter ended in March - Earnings Summary1
15.05.Fortress Biotech GAAP EPS of -$1.03 beats by $0.70, revenue of $13M misses by $1.13M3
15.05.Fortress Biotech, Inc. - 10-Q, Quarterly Report1
15.05.Fortress Biotech, Inc.: Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights72Fortress' late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025 FDA...
► Artikel lesen
29.03.Fortress Biotech Inc reports results for the quarter ended in December - Earnings Summary6
28.03.Fortress Biotech GAAP EPS of -$8.47 beats by $0.64, revenue of $84.51M beats by $4.83M8
28.03.Fortress Biotech, Inc.: Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights2.047Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application filing...
► Artikel lesen
28.03.Fortress Biotech, Inc. - 8-K, Current Report-
15.03.Fortress Biotech shares upgraded with $10 price target6
12.03.Fortress Biotech, Inc.: Fortress Biotech to Participate in 36th Annual ROTH Conference1
04.03.Fortress Biotech, Inc.: Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease154Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for Menkes disease Cyprium Therapeutics, a majority-owned...
► Artikel lesen
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 34.157The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS00941Q2030 AIRNET...
► Artikel lesen
13.02.Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrow5
26.01.Fortress Biotech, Inc. - 8-K, Current Report6
10.01.Fortress Biotech 9.375% CUM PFD A goes ex-dividend tomorrow11
03.01.Fortress Biotech, Inc. - 8-K, Current Report4
03.01.Fortress Biotech, Inc.: Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules7
29.12.23Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet6
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1